Upon recommendation of the Nominating and Governance Committee of the Board of Directors of Bionano Genomics, Inc. (the Company), on February 17, 2022, the Board appointed Aleksandar Rajkovic as a Class III director, effective as of such date, to serve in such capacity until the Company's 2024 annual meeting of stockholders. Dr. Rajkovic will receive compensation for his service as a director in accordance with the Company's Non-Employee Director Compensation Policy, as amended (the Compensation Policy).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 USD | +2.70% | +19.31% | -39.68% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.68% | 76.22M | |
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+1.10% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- BNGO Stock
- News Bionano Genomics, Inc.
- Bionano Genomics, Inc. Appoints Aleksandar Rajkovic as Class III Director